1st Quarter - Report

SOCIETY FOR MATERNAL-FETAL MEDICINE for SOCIETY FOR MATERNAL-FETAL MEDICINE

Firm
Client
Income
—
Expenses
$10,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2025 and FY 2026 funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the Agency for Healthcare Research & Quality, and the Health Resources and Services Administration

LobbyistCovered position, as disclosed
REBECCA ABBOTT New —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Natl Institutes of Health (NIH); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA)

Health Issues HCR

inclusion of pregnant and lactating women in clinical trials, federal support for maternal mortality review committees

LobbyistCovered position, as disclosed
REBECCA ABBOTT New —

Contacted: Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.